BSX Boston Scientific

• $10M bought by 5 insiders
• None no sales outside a trading plan
• $23M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Susan E Morano Director
   Buy
   $100K 2,040 shares at $49.22 +17% to stake
   Traded Aug 25 Filed Aug 26
   ↗
3. David C Habiger Director
   Buy
   $100K 2,100 shares at $47.59 +14% to stake
   Traded Aug 5 Filed Aug 7
   ↗
4. David C Habiger Director
   Buy
   $57K 1,182 shares at $48.13 +8.5% to stake
   Traded Aug 3–4 Filed Aug 5
   ↗
5. Michael F Mahoney CEO
   Buy
   $9M 186,240 shares at $48.33 +13% to stake
   Traded Aug 3 Filed Aug 5
   ↗
6. Edward J Ludwig Director
   Buy
   $227K 5,000 shares at $45.48 +20% to stake
   Traded Jul 31 Filed Aug 3
   ↗
7. Cheryl Pegus Director
   Buy
   $100K 1,770 shares at $56.49 New stake
   Traded May 20 Filed May 21
   ↗
8. Edward J Ludwig Director
   Buy
   $203K 3,580 shares at $56.68 +16% to stake
   Traded May 20 Filed May 21
   ↗
9. David C Habiger Director
   Buy
   $251K 4,450 shares at $56.43 +47% to stake
   Traded May 19–20 Filed May 21
   ↗
10. Michael F Mahoney CEO
    Planned sale
    $15M 160,901 shares at $93.49 10% of stake
    Traded Feb 2 Filed Feb 3
    ↗
11. Arthur C Butcher EVP& Grp Pres, MedSurg & APAC
    Planned sale
    $1.8M 17,313 shares at $101.55 42% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
    ↗
12. Ellen M Zane Director
    Planned sale
    $1.3M 12,891 shares at $98.28 35% of stake
    Traded Nov 6, 2025 Filed Nov 6, 2025
    ↗
13. Joseph Michael Fitzgerald EVP & Group Pres, Cardiology
    Planned sale
    $5M 50,000 shares at $99.47 22% of stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗
14. Ellen M Zane Director
    Planned sale
    $1.3M 12,891 shares at $101.38 35% of stake
    Traded Oct 27–28 Filed Oct 28, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 44 option exercises, 37 share withholdings for taxes, 20 stock grants, 5 gifts, and 5 other transactions.